Community Health Sells 4 Rural Hospitals

Financially troubled Community Health Systems (NYSE: CYH) announced the sale of four rural hospitals on September 28, as it tries to pare down its $15 billion in debt. And more announcements are in the works. Curae Health, Inc., a not-for-profit organization dedicated to supporting rural healthcare services, agreed to take on the four facilities, three […]

Hospital Deals Lag 2015’s Total

Hospital transactions have trickled in during the first three quarters of 2016. To date, 68 mergers or acquisitions have been announced (64 of them for U.S. hospital or health systems), although there have been many more partnerships, strategic alliances and joint ventures in the same period. For our database, those deals don’t count.

Digital Health Deals on Track to Pass 2015

So far in 2016, eHealth is only four deals away from surpassing 2015’s total of 126, and nearly $20 billion has been spent (out of 20 disclosed prices). Nine deals have been announced in September, most of which exemplify how eHealth touches many areas of healthcare, beyond the expected revenue cycle management (RCM), electronic health […]

Medical Device Sector Picks Up in Q3:16

In the first eight months of 2016, 80 transactions were announced in the Medical Device sector, making it unlikely this year’s deal volume would surpass last year’s total of 114 deals. As the third quarter wraps up, the sector’s deal volume has reached 90 deals: 31 in Q1, 27 in Q2, and 32 as of […]

MACRA Is Spooking Physician Medical Groups

With a full quarter left to go in 2016, mergers and acquisitions in the Physician Medical Group sector have caught up to last year’s total number of transactions. In 2015, 89 deals were announced. Through September 26, 2016, the sector’s deal volume has reached 88. One factor contributing to the increase in activity is the […]

Preliminary Data: Q3 M and A

There’s still one week left to go in the month of September, and the third quarter, but the trends have already established themselves. Merger and acquisition activity in health care dropped 20% compared with the previous quarter, down to 331 deals compared with 415 in Q2:16. The third quarter also pales in comparison to the same […]

Allergan Is Bullish on Biotech

Ever since Allergan (NYSE: AGN) completed the $40.5 billion sale of its generics business to Teva Pharmaceutical Industries (NYSE: TEVA) on August 2, the pharma giant is targeting biotech companies with a vengeance. In September alone (and we’re only talking about three weeks at this point), the company has announced four deals, totalling $1.28 billion. Year-to-date, Allergan has announced […]

Allergan Adds Tobira to Its GI Pipeline

Allergan plc (NYSE: AGN) shows no signs of slowing its acquisition pace this year, and just solidified its lead in therapeutics for nonalcoholic steatohepatitis (NASH), an incurable disease affecting approximately 5% of the U.S. population. The pharma giant announced its acquisition of Tobira Therapeutics Inc. (NASDAQ: TBRA), This transaction marks the company’s eighth in 2016, […]